<unk> , sold under the brand name Vumerity, is a medication used for the treatment of relapsing forms of multiple sclerosis (MS).<unk>  was approved for medical use in the United States in October 2019, and in the European Union in November 2021.
Diroximel fumarate
Diprobase
Miproxifene phosphate
Gadoteric acid
Penicilloic acid
Nimesulide
Guanethidine
Famprofazone